Antihypertensive Pharmacology

Overview

Journal West J Med

Specialty General Medicine

Date 1980 May 1

PMID 6992462

Citations 5

Authors

J G Gerber

C R Freed

A S Nies

Affiliations

Soon will be listed here.

Abstract

Although drug treatment of hypertension is associated with improved survival and decreased vascular complications, drug compliance is a major problem in the control of hypertension. All antihypertensive medications are associated with side effects; thus, it is a physician's responsibility to explain to each patient the side effects of the drugs he prescribes to treat hypertension, and to instill in the patient a sense of necessity for the treatment of hypertension. The choice of antihypertensive drug should be made based on each patient's lifestyle, overall health and ability to tolerate the drug. Ideally, the antihypertensive regimen should be simple, effective, convenient to take and have very few side effects.

Citing Articles

Synthesis of potent vasodilating agents: in silico and in vitro evaluation of 6-(4-substitutedphenyl)-3-pyridazinone derivatives as potential hydralazine analogues.

Aziz M, Mohamed K, Farag D, Khalifa A, Mahmoud Z Sci Rep. 2024; 14(1):29514.

PMID: 39604410 PMC: 11603188. DOI: 10.1038/s41598-024-79697-1.

Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.

Bays H, Fitch A, Christensen S, Burridge K, Tondt J Obes Pillars. 2023; 2:100018.

PMID: 37990711 PMC: 10662004. DOI: 10.1016/j.obpill.2022.100018.

Effect of Central Corticotropin-Releasing Factor on Hepatic Lipid Metabolism and Inflammation-Related Gene Expression in Rats.

Nakade Y, Kitano R, Yamauchi T, Kimoto S, Sakamoto K, Inoue T Int J Mol Sci. 2021; 22(8).

PMID: 33920431 PMC: 8069855. DOI: 10.3390/ijms22083940.

The Effect of Acetyl Salicylic Acid Induced Nitric Oxide Synthesis in the Normalization of Hypertension through the Stimulation of Renal Cortexin Synthesis and by the Inhibition of Dermcidin Isoform 2, A Hypertensive Protein Production.

Ghosh R, Bank S, Maji U, Bhattacharya R, Guha S, Khan N Int J Biomed Sci. 2014; 10(3):158-66.

PMID: 25324696 PMC: 4199471.

Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.

Maheshwari M, Roberts J, Desutter B, Duong K, Tingling J, Fawver J Biochemistry. 2010; 49(49):10371-80.

PMID: 21058733 PMC: 3033120. DOI: 10.1021/bi101249p.

References

McNeil B, Varady P, BURROWS B, Adelstein S . Measures of clinical efficacy. Cost-effectiveness calculations in the diagnosis and treatment of hypertensive renovascular disease. N Engl J Med. 1975; 293(5):216-21. DOI: 10.1056/NEJM197507312930502. View

Mroczek W, Davidov M, Finnerty Jr F . Intravenous clonidine in hypertensive patients. Clin Pharmacol Ther. 1973; 14(5):847-51. DOI: 10.1002/cpt1973145847. View

PAGE I, CORCORAN A, DUSTAN H, KOPPANYI T . Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation. 1955; 11(2):188-98. DOI: 10.1161/01.cir.11.2.188. View

Lund-Johansen P, Ohm O . Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension. Br J Clin Pharmacol. 1977; 4(2):147-51. PMC: 1429031. DOI: 10.1111/j.1365-2125.1977.tb00686.x. View

Weir E, Chidsey C, WEIL J, GROVER R . Minoxidil reduces pulmonary vascular resistance in dogs and cattle. J Lab Clin Med. 1976; 88(6):885-94. View

LARAGH J . Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med. 1973; 55(3):261-74. DOI: 10.1016/0002-9343(73)90128-9. View

Esler M . Effect of practolol on blood pressure and renin release in man. Clin Pharmacol Ther. 1974; 15(5):484-9. DOI: 10.1002/cpt1974155484. View

Graham R, Thornell I, Gain J, Bagnoli C, Oates H, Stokes G . Prazosin: the first-dose phenomenon. Br Med J. 1976; 2(6047):1293-4. PMC: 1689975. DOI: 10.1136/bmj.2.6047.1293. View

PETTINGER W, MITCHELL H . Minoxidil--an alternative to nephrectomy for refractory hypertension. N Engl J Med. 1973; 289(4):167-71. DOI: 10.1056/NEJM197307262890401. View

10.

Frohlich E, Kozul V, TARAZI R, DUSTAN H . Physiological comparison of labile and essential hypertension. Circ Res. 1970; 27(1 Suppl 1):55-69. View

11.

PETTINGER W . Drug therapy: clonidine, a new antihypertensive drug. N Engl J Med. 1975; 293(23):1179-80. DOI: 10.1056/NEJM197512042932306. View

12.

Kannel W . Role of blood pressure in cardiovascular morbidity and mortality. Prog Cardiovasc Dis. 1974; 17(1):5-24. DOI: 10.1016/0033-0620(74)90034-6. View

13.

Zanchetti A, Leonetti G, Morganti A, Terzoli L . Considerations on physiopathological approaches to the treatment of hypertension. Clin Exp Pharmacol Physiol Suppl. 1978; 4:1-9. View

14.

Smith R, Kruszyna H . Nitroprusside produces cyanide poisoning via reaction with hemoglobin. J Pharmacol Exp Ther. 1974; 191(3):557-63. View

15.

Haynes R, Sackett D, Gibson E, Taylor D, Hackett B, Roberts R . Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976; 1(7972):1265-8. DOI: 10.1016/s0140-6736(76)91737-2. View

16.

OFallon W, Labarthe D, Kurland L . Rauwolfia derivatives and breast cancer. A case/control study in Olmsted County, Minnesota. Lancet. 1975; 2(7929):292-6. DOI: 10.1016/s0140-6736(75)92730-0. View

17.

PERERA G . Edema and congestive failure related to administration of Rauwolfia serpentina. J Am Med Assoc. 1955; 159(5):439. View

18.

Au W, Dring L, Grahame-Smith D, Isaac P, Williams R . The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects. Biochem J. 1972; 129(1):1-10. PMC: 1174035. DOI: 10.1042/bj1290001. View

19.

Bolli P, Wood A, Simpson F . Effects of prazosin in patients with hypertension. Clin Pharmacol Ther. 1976; 20(2):138-41. DOI: 10.1002/cpt1976202138. View

20.

Briant R, Reid J, Dollery C . Interaction between clonidine and desipramine in man. Br Med J. 1973; 1(5852):522-3. PMC: 1588665. DOI: 10.1136/bmj.1.5852.522. View